ASTRA PILL CUTS HARD-TO-TREAT BLOOD PRESSURE IN LATE-STAGE TRIAL

Summary from the TLDR newsletter

AstraZeneca's experimental hypertension pill reduced blood pressure by more than twice as much as standard treatment during a large late-stage study. The drugmaker aims to file for regulatory approval by the end of the year. More studies are still required to confirm safety and assess outcomes over a long period of time before use of the pill can be approved. The drug works by reducing the production of aldosterone, a hormone made in the adrenal gland that helps the body regulate levels of salt and water.